|
The Collaborative Ependymoma Research Network (CERN) Foundation is a Nonprofit organization composed of scientists and adult and pediatric cancer researchers who work together to develop new treatments for Ependymoma, a type of primary brain or spinal cord tumor that occurs in both children and adults, and improve the outcomes and care of patients.〔("MD Anderson Cancer Center, Research" ), 2012-10-08〕 The organization is headquartered in Dayton, Ohio, USA.〔("About CERN" ), 2012-09-06〕 (The CERN Foundation’s ) research is based on a model that includes preclinical evaluation of new and FDA-approved drugs in laboratory models of ependymoma. The drugs are tested in clinical trials involving both pediatric and adult cancer centers from within the CERN network. The CERN Foundation’s research is needed to design better treatment plans for patients with ependymoma.〔Armstrong, TS; Vera-Bolanos, E; Nebiyou Bekele, B; Aldape, K; Gilbert, MR, (“Adult ependymal tumors: prognosis and the M.D. Anderson Cancer Center experience” ), “Neuro-Oncology”, August 2010〕 The CERN Foundation differs from other cancer research organizations through its focus on collaborative research and sharing knowledge and available resources among participating researchers.〔 ==History== In November 2006, the concept of creating an international group to develop new treatments for ependymoma was proposed to Mark Gilbert, M.D., Deputy Chairman of Neuro-Oncology at MD Anderson Cancer Center, during a meeting with an ependymoma survivor.〔("About CERN, History" ), 2012-09-06〕 Shortly thereafter, Dr. Gilbert was joined by Richard Gilbertson, M.D., Ph.D. and Amar Gajjar, M.D. of St. Jude Children’s Research Hospital, and Ken Adalpe, M.D. and Terri Armstrong, Ph.D. of the University of Texas MD Anderson Cancer Center. After the organization created its initial vision and established its leadership, additional partners joined the CERN team. Today, investigators representing many internationally recognized cancer centers are partnered with the CERN Foundation.〔("CERN Centers" ), 2012-09-06〕 On April 19, 2012 the CERN Foundation commemorated the first Ependymoma Awareness Day in Houston with a mass butterfly release.〔("Ependymoma Awareness Day" ), 2012-09-06〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「The CERN Foundation」の詳細全文を読む スポンサード リンク
|